Swiss pharmaceuticals giant Roche has announced a 12 percent jump in its turnover to US$28.7 billion in the first nine months of 2007.

Growth was particularly strong in the Asia-Pacific region.

The bird flu drug, Tamiflu has added to the profits by posting a 12 percent rise.

Some countries have started stockpiling the drug, which was developed as a weapon against any bird-flu pandemic.